10 20 30 40 50 60 70 80 3H7W - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER TRANSCRIPTION 28-APR-09 3H7W
TITLE CRYSTAL STRUCTURE OF THE HIGH AFFINITY HETERODIMER OF HIF2 TITLE 2 ALPHA AND ARNT C-TERMINAL PAS DOMAINS WITH THE ARTIFICIAL TITLE 3 LIGAND THS017
COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HIF2ALPHA C-TERMINAL PAS DOMAIN (UNP RESIDUES 239 COMPND 5 TO 350); COMPND 6 SYNONYM: EPAS-1, MEMBER OF PAS PROTEIN 2, BASIC-HELIX-LOOP- COMPND 7 HELIX-PAS PROTEIN MOP2, HYPOXIA-INDUCIBLE FACTOR 2 ALPHA, COMPND 8 HIF-2 ALPHA, HIF2 ALPHA, HIF-1 ALPHA-LIKE FACTOR, HLF; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; COMPND 13 CHAIN: B; COMPND 14 FRAGMENT: ARNT C-TERMINAL PAS DOMAIN (UNP RESIDUES 356 TO COMPND 15 470); COMPND 16 SYNONYM: ARNT PROTEIN, CLASS E BASIC HELIX-LOOP-HELIX COMPND 17 PROTEIN 2, BHLHE2, DIOXIN RECEPTOR, NUCLEAR TRANSLOCATOR, COMPND 18 HYPOXIA-INDUCIBLE FACTOR 1 BETA, HIF-1 BETA; COMPND 19 ENGINEERED: YES; COMPND 20 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EPAS1, HIF2A, HYPOXIA INDUCIBLE FACTOR 2 ALPHA, MOP2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PHIS-GB1-HIF2APAS-B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: ARNT, ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR, SOURCE 16 BHLHE2; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 19 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 20 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 21 EXPRESSION_SYSTEM_PLASMID: PHIS-GB1-ARNT-PAS-B
KEYWDS PAS DOMAIN, HETERODIMER, PROTEIN LIGAND COMPLEX., ACTIVATOR, KEYWDS 2 ANGIOGENESIS, CONGENITAL ERYTHROCYTOSIS, DEVELOPMENTAL KEYWDS 3 PROTEIN, DIFFERENTIATION, DISEASE MUTATION, DNA-BINDING, KEYWDS 4 HYDROXYLATION, NUCLEUS, PHOSPHOPROTEIN, TRANSCRIPTION, KEYWDS 5 TRANSCRIPTION REGULATION, UBL CONJUGATION, ALTERNATIVE KEYWDS 6 SPLICING, POLYMORPHISM
EXPDTA X-RAY DIFFRACTION
AUTHOR J.M.KEY,T.H.SCHEUERMANN,P.C.ANDERSON,V.DAGGETT,K.H.GARDNER
REVDAT 1 12-JAN-10 3H7W 0
JRNL AUTH J.KEY,T.H.SCHEUERMANN,P.C.ANDERSON,V.DAGGETT, JRNL AUTH 2 K.H.GARDNER JRNL TITL PRINCIPLES OF LIGAND BINDING WITHIN A COMPLETELY JRNL TITL 2 BURIED CAVITY IN HIF2ALPHA PAS-B JRNL REF J.AM.CHEM.SOC. V. 131 17647 2009 JRNL REFN ISSN 0002-7863 JRNL PMID 19950993 JRNL DOI 10.1021/JA9073062
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.71 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 28092 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1409 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.68 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1827 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.20 REMARK 3 BIN R VALUE (WORKING SET) : 0.2980 REMARK 3 BIN FREE R VALUE SET COUNT : 103 REMARK 3 BIN FREE R VALUE : 0.3720 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1857 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 182 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.111 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.111 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.073 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.094 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1913 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2594 ; 1.481 ; 1.943 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 234 ; 6.839 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 95 ;38.129 ;24.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 337 ;13.196 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 11 ;16.084 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 276 ; 0.102 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1466 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 864 ; 0.214 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1334 ; 0.303 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 143 ; 0.100 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 50 ; 0.206 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 24 ; 0.204 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1167 ; 1.027 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1840 ; 1.588 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 875 ; 2.452 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 750 ; 3.559 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 3H7W COMPLIES WITH FORMAT V. 3.20, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAY-09. REMARK 100 THE RCSB ID CODE IS RCSB052803.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97915 REMARK 200 MONOCHROMATOR : CUSTOM REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : SBC-2 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28092 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 24.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.51900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: PDB ENTRY 3F1P REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BISTRIS, 17% PEG3350, PH 6.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 36.94500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.36350 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 36.94500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 41.36350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: TO GENERATE THE BIOLOGICALLY RELEVANT COMPLEX, THE REMARK 300 SYMMETRY OPERATOR (1/2-X,Y-1/2,1-Z) SHOULD APPLIED TO CHAIN B.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 234 REMARK 465 GLU A 235 REMARK 465 ASN A 328 REMARK 465 PRO A 329 REMARK 465 ARG A 330 REMARK 465 ASN A 331 REMARK 465 LEU A 332 REMARK 465 GLN A 333 REMARK 465 ASN A 350 REMARK 465 GLY B 350 REMARK 465 GLU B 351 REMARK 465 PHE B 352 REMARK 465 LYS B 353 REMARK 465 GLY B 354 REMARK 465 LEU B 355 REMARK 465 ASN B 356 REMARK 465 VAL B 357 REMARK 465 SER B 468 REMARK 465 GLN B 469 REMARK 465 GLU B 470
REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 263 CD OE1 OE2 REMARK 480 GLN A 301 CD OE1 NE2 REMARK 480 LYS A 349 CE NZ REMARK 480 GLN B 359 CG CD OE1 NE2 REMARK 480 GLU B 455 CD OE1 OE2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS A 349 CD LYS A 349 CE -1.009 REMARK 500 GLU B 455 CG GLU B 455 CD -0.093 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 349 CG - CD - CE ANGL. DEV. = 21.5 DEGREES REMARK 500 LYS A 349 CD - CE - NZ ANGL. DEV. = 16.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 168 DISTANCE = 6.32 ANGSTROMS
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 018 A 1
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3F1O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HIGH AFFINITY HETERODIMER OF HIF2 REMARK 900 C-TERMINAL PAS DOMAINS IN COMPLEX WITH THE ARTIFICIAL REMARK 900 LIGAND THS-044. REMARK 900 RELATED ID: 3F1P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE APO-HIGH AFFINITY HIF2 PAS-B REMARK 900 HETERODIMER. REMARK 900 RELATED ID: 3F1N RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HIGH AFFINITY HETERODIMER OF HIF2 REMARK 900 C-TERMINAL PAS DOMAINS WITH INTERNALLY BOUND ETHYLENE REMARK 900 GLYCOL. REMARK 900 RELATED ID: 1P97 RELATED DB: PDB REMARK 900 SOLUTION NMR STRUCTURE OF THE HIF2ALPHA C-TERMINAL PAS REMARK 900 DOMAIN. REMARK 900 RELATED ID: 1X0O RELATED DB: PDB REMARK 900 SOLUTION NMR STRUCTURE OF THE ARNT C-TERMINAL PAS DOMAIN. REMARK 900 RELATED ID: 2A24 RELATED DB: PDB REMARK 900 NMR-GUIDED MODEL OF THE HETERODIMER OF WILD-TYPE HIF2ALPHA REMARK 900 AND ARNT C-TERMINAL PAS DOMAIN. REMARK 900 RELATED ID: 2B02 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ARNT C-TERMINAL PAS DOMAIN. REMARK 900 RELATED ID: 3H82 RELATED DB: PDB REMARK 900 HETERODIMER OF HIF2 ALPHA AND ARNT C-TERMINAL PAS DOMAINS REMARK 900 WITH THE ARTIFICIAL LIGAND THS020
DBREF 3H7W A 239 350 UNP Q99814 EPAS1_HUMAN 239 350 DBREF 3H7W B 356 470 UNP P27540 ARNT_HUMAN 356 470
SEQADV 3H7W GLY A 234 UNP Q99814 EXPRESSION TAG SEQADV 3H7W GLU A 235 UNP Q99814 EXPRESSION TAG SEQADV 3H7W PHE A 236 UNP Q99814 EXPRESSION TAG SEQADV 3H7W LYS A 237 UNP Q99814 EXPRESSION TAG SEQADV 3H7W GLY A 238 UNP Q99814 EXPRESSION TAG SEQADV 3H7W GLU A 247 UNP Q99814 ARG 247 ENGINEERED SEQADV 3H7W GLY B 350 UNP P27540 EXPRESSION TAG SEQADV 3H7W GLU B 351 UNP P27540 EXPRESSION TAG SEQADV 3H7W PHE B 352 UNP P27540 EXPRESSION TAG SEQADV 3H7W LYS B 353 UNP P27540 EXPRESSION TAG SEQADV 3H7W GLY B 354 UNP P27540 EXPRESSION TAG SEQADV 3H7W LEU B 355 UNP P27540 EXPRESSION TAG SEQADV 3H7W ARG B 362 UNP P27540 GLU 362 ENGINEERED
SEQRES 1 A 117 GLY GLU PHE LYS GLY LEU ASP SER LYS THR PHE LEU SER SEQRES 2 A 117 GLU HIS SER MET ASP MET LYS PHE THR TYR CYS ASP ASP SEQRES 3 A 117 ARG ILE THR GLU LEU ILE GLY TYR HIS PRO GLU GLU LEU SEQRES 4 A 117 LEU GLY ARG SER ALA TYR GLU PHE TYR HIS ALA LEU ASP SEQRES 5 A 117 SER GLU ASN MET THR LYS SER HIS GLN ASN LEU CYS THR SEQRES 6 A 117 LYS GLY GLN VAL VAL SER GLY GLN TYR ARG MET LEU ALA SEQRES 7 A 117 LYS HIS GLY GLY TYR VAL TRP LEU GLU THR GLN GLY THR SEQRES 8 A 117 VAL ILE TYR ASN PRO ARG ASN LEU GLN PRO GLN CYS ILE SEQRES 9 A 117 MET CYS VAL ASN TYR VAL LEU SER GLU ILE GLU LYS ASN SEQRES 1 B 121 GLY GLU PHE LYS GLY LEU ASN VAL CYS GLN PRO THR ARG SEQRES 2 B 121 PHE ILE SER ARG HIS ASN ILE GLU GLY ILE PHE THR PHE SEQRES 3 B 121 VAL ASP HIS ARG CYS VAL ALA THR VAL GLY TYR GLN PRO SEQRES 4 B 121 GLN GLU LEU LEU GLY LYS ASN ILE VAL GLU PHE CYS HIS SEQRES 5 B 121 PRO GLU ASP GLN GLN LEU LEU ARG ASP SER PHE GLN GLN SEQRES 6 B 121 VAL VAL LYS LEU LYS GLY GLN VAL LEU SER VAL MET PHE SEQRES 7 B 121 ARG PHE ARG SER LYS ASN GLN GLU TRP LEU TRP MET ARG SEQRES 8 B 121 THR SER SER PHE THR PHE GLN ASN PRO TYR SER ASP GLU SEQRES 9 B 121 ILE GLU TYR ILE ILE CYS THR ASN THR ASN VAL LYS ASN SEQRES 10 B 121 SER SER GLN GLU
HET 018 A 1 20
HETNAM 018 2-NITRO-N-(THIOPHEN-3-YLMETHYL)-4-(TRIFLUOROMETHYL) HETNAM 2 018 ANILINE
FORMUL 3 018 C12 H9 F3 N2 O2 S FORMUL 4 HOH *182(H2 O)
HELIX 1 1 LEU A 239 SER A 241 5 3 HELIX 2 2 ARG A 260 GLY A 266 1 7 HELIX 3 3 HIS A 268 LEU A 273 1 6 HELIX 4 4 SER A 276 TYR A 281 5 6 HELIX 5 5 HIS A 282 LEU A 284 5 3 HELIX 6 6 ASP A 285 GLY A 300 1 16 HELIX 7 7 ARG B 379 GLY B 385 1 7 HELIX 8 8 GLN B 387 LEU B 391 5 5 HELIX 9 9 ASN B 395 CYS B 400 5 6 HELIX 10 10 ASP B 404 VAL B 416 1 13
SHEET 1 A 5 PHE A 254 CYS A 257 0 SHEET 2 A 5 THR A 243 HIS A 248 -1 N GLU A 247 O THR A 255 SHEET 3 A 5 CYS A 336 VAL A 343 -1 O CYS A 339 N SER A 246 SHEET 4 A 5 TYR A 316 ILE A 326 -1 N ILE A 326 O CYS A 336 SHEET 5 A 5 GLN A 301 VAL A 303 -1 N VAL A 302 O GLY A 323 SHEET 1 B 5 PHE A 254 CYS A 257 0 SHEET 2 B 5 THR A 243 HIS A 248 -1 N GLU A 247 O THR A 255 SHEET 3 B 5 CYS A 336 VAL A 343 -1 O CYS A 339 N SER A 246 SHEET 4 B 5 TYR A 316 ILE A 326 -1 N ILE A 326 O CYS A 336 SHEET 5 B 5 TYR A 307 LEU A 310 -1 N MET A 309 O VAL A 317 SHEET 1 C 5 PHE B 373 VAL B 376 0 SHEET 2 C 5 ARG B 362 HIS B 367 -1 N ARG B 366 O THR B 374 SHEET 3 C 5 TYR B 456 ASN B 463 -1 O CYS B 459 N SER B 365 SHEET 4 C 5 TRP B 436 PHE B 446 -1 N PHE B 444 O ILE B 458 SHEET 5 C 5 LEU B 423 ARG B 430 -1 N PHE B 429 O LEU B 437
SITE 1 AC1 14 HIS A 248 MET A 252 ALA A 277 TYR A 281 SITE 2 AC1 14 MET A 289 SER A 292 HIS A 293 VAL A 302 SITE 3 AC1 14 SER A 304 TYR A 307 MET A 309 THR A 321 SITE 4 AC1 14 CYS A 339 ASN A 341
CRYST1 73.890 82.727 41.158 90.00 106.48 90.00 C 1 2 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.013534 0.000000 0.004003 0.00000
SCALE2 0.000000 0.012088 0.000000 0.00000
SCALE3 0.000000 0.000000 0.025337 0.00000